6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists

6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1 H BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS Abstract Rr R R 4 R N-R 3 (I) The present invention provides 6-substituted 2,3,4,5-tetrahydro- 1 H benzo[d]azepines of Formula I as selective 5-HT2C receptor agonists for the treatment of 5-HT2C associated disorders in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SIEDEM, CHRISTOPHER STEPHEN, BRINER, KARIN, RODRIGUEZ, MICHAEL JOHN, SINGH, AJAY, MAZANETZ, MICHAEL PHILIP, ALLEN, JOHN GORDON, COHEN, MICHAEL PHILIP, REINHARD, MATTHEW ROBERT, TIDWELL, MICHAEL WADE, BOYD, STEVEN ARMEN, LEE, WAI-MAN, CONWAY, RICHARD GERARD, HELLMAN, SARAH LYNNE, GALKA, CHRISTOPHER STANLEY, ROTHHAAR, ROGER RYAN, WILLIAMS, ANDREW CAERWYN, DEO, ARUNDHATI S, ZHANG, DEYI, VICTOR, FRANTZ, MARTINEZ-GRAU, MARIA ANGELES
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SIEDEM, CHRISTOPHER STEPHEN
BRINER, KARIN
RODRIGUEZ, MICHAEL JOHN
SINGH, AJAY
MAZANETZ, MICHAEL PHILIP
ALLEN, JOHN GORDON
COHEN, MICHAEL PHILIP
REINHARD, MATTHEW ROBERT
TIDWELL, MICHAEL WADE
BOYD, STEVEN ARMEN
LEE, WAI-MAN
CONWAY, RICHARD GERARD
HELLMAN, SARAH LYNNE
GALKA, CHRISTOPHER STANLEY
ROTHHAAR, ROGER RYAN
WILLIAMS, ANDREW CAERWYN
DEO, ARUNDHATI S
ZHANG, DEYI
VICTOR, FRANTZ
MARTINEZ-GRAU, MARIA ANGELES
description 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1 H BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS Abstract Rr R R 4 R N-R 3 (I) The present invention provides 6-substituted 2,3,4,5-tetrahydro- 1 H benzo[d]azepines of Formula I as selective 5-HT2C receptor agonists for the treatment of 5-HT2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: I where R is -C= C-R'0 , -O-R , -S-R' 4 , or NR 24R ; and other substituents are as defined in the specification. (5273342_l):KZA
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2011202788BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2011202788BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2011202788BB23</originalsourceid><addsrcrecordid>eNqNyjEOwiAUAFAWB6PegcERkkKtdrWNhtGhTsY0tHyVxADh_w729C4ewOktb8kue4nTgORpInBci1LsRCUJKNvXx-UolZEDhDne3N3OkHwA5BZ5JU2nW55hhEQxc_uMwSPhmi0e9o2w-bli2_Opa42EFHvAZEcIQP3xqguldKEPdd00uvyzfQG2RDaW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists</title><source>esp@cenet</source><creator>SIEDEM, CHRISTOPHER STEPHEN ; BRINER, KARIN ; RODRIGUEZ, MICHAEL JOHN ; SINGH, AJAY ; MAZANETZ, MICHAEL PHILIP ; ALLEN, JOHN GORDON ; COHEN, MICHAEL PHILIP ; REINHARD, MATTHEW ROBERT ; TIDWELL, MICHAEL WADE ; BOYD, STEVEN ARMEN ; LEE, WAI-MAN ; CONWAY, RICHARD GERARD ; HELLMAN, SARAH LYNNE ; GALKA, CHRISTOPHER STANLEY ; ROTHHAAR, ROGER RYAN ; WILLIAMS, ANDREW CAERWYN ; DEO, ARUNDHATI S ; ZHANG, DEYI ; VICTOR, FRANTZ ; MARTINEZ-GRAU, MARIA ANGELES</creator><creatorcontrib>SIEDEM, CHRISTOPHER STEPHEN ; BRINER, KARIN ; RODRIGUEZ, MICHAEL JOHN ; SINGH, AJAY ; MAZANETZ, MICHAEL PHILIP ; ALLEN, JOHN GORDON ; COHEN, MICHAEL PHILIP ; REINHARD, MATTHEW ROBERT ; TIDWELL, MICHAEL WADE ; BOYD, STEVEN ARMEN ; LEE, WAI-MAN ; CONWAY, RICHARD GERARD ; HELLMAN, SARAH LYNNE ; GALKA, CHRISTOPHER STANLEY ; ROTHHAAR, ROGER RYAN ; WILLIAMS, ANDREW CAERWYN ; DEO, ARUNDHATI S ; ZHANG, DEYI ; VICTOR, FRANTZ ; MARTINEZ-GRAU, MARIA ANGELES</creatorcontrib><description>6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1 H BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS Abstract Rr R R 4 R N-R 3 (I) The present invention provides 6-substituted 2,3,4,5-tetrahydro- 1 H benzo[d]azepines of Formula I as selective 5-HT2C receptor agonists for the treatment of 5-HT2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: I where R is -C= C-R'0 , -O-R , -S-R' 4 , or NR 24R ; and other substituents are as defined in the specification. (5273342_l):KZA</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120426&amp;DB=EPODOC&amp;CC=AU&amp;NR=2011202788B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120426&amp;DB=EPODOC&amp;CC=AU&amp;NR=2011202788B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SIEDEM, CHRISTOPHER STEPHEN</creatorcontrib><creatorcontrib>BRINER, KARIN</creatorcontrib><creatorcontrib>RODRIGUEZ, MICHAEL JOHN</creatorcontrib><creatorcontrib>SINGH, AJAY</creatorcontrib><creatorcontrib>MAZANETZ, MICHAEL PHILIP</creatorcontrib><creatorcontrib>ALLEN, JOHN GORDON</creatorcontrib><creatorcontrib>COHEN, MICHAEL PHILIP</creatorcontrib><creatorcontrib>REINHARD, MATTHEW ROBERT</creatorcontrib><creatorcontrib>TIDWELL, MICHAEL WADE</creatorcontrib><creatorcontrib>BOYD, STEVEN ARMEN</creatorcontrib><creatorcontrib>LEE, WAI-MAN</creatorcontrib><creatorcontrib>CONWAY, RICHARD GERARD</creatorcontrib><creatorcontrib>HELLMAN, SARAH LYNNE</creatorcontrib><creatorcontrib>GALKA, CHRISTOPHER STANLEY</creatorcontrib><creatorcontrib>ROTHHAAR, ROGER RYAN</creatorcontrib><creatorcontrib>WILLIAMS, ANDREW CAERWYN</creatorcontrib><creatorcontrib>DEO, ARUNDHATI S</creatorcontrib><creatorcontrib>ZHANG, DEYI</creatorcontrib><creatorcontrib>VICTOR, FRANTZ</creatorcontrib><creatorcontrib>MARTINEZ-GRAU, MARIA ANGELES</creatorcontrib><title>6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists</title><description>6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1 H BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS Abstract Rr R R 4 R N-R 3 (I) The present invention provides 6-substituted 2,3,4,5-tetrahydro- 1 H benzo[d]azepines of Formula I as selective 5-HT2C receptor agonists for the treatment of 5-HT2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: I where R is -C= C-R'0 , -O-R , -S-R' 4 , or NR 24R ; and other substituents are as defined in the specification. (5273342_l):KZA</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEOwiAUAFAWB6PegcERkkKtdrWNhtGhTsY0tHyVxADh_w729C4ewOktb8kue4nTgORpInBci1LsRCUJKNvXx-UolZEDhDne3N3OkHwA5BZ5JU2nW55hhEQxc_uMwSPhmi0e9o2w-bli2_Opa42EFHvAZEcIQP3xqguldKEPdd00uvyzfQG2RDaW</recordid><startdate>20120426</startdate><enddate>20120426</enddate><creator>SIEDEM, CHRISTOPHER STEPHEN</creator><creator>BRINER, KARIN</creator><creator>RODRIGUEZ, MICHAEL JOHN</creator><creator>SINGH, AJAY</creator><creator>MAZANETZ, MICHAEL PHILIP</creator><creator>ALLEN, JOHN GORDON</creator><creator>COHEN, MICHAEL PHILIP</creator><creator>REINHARD, MATTHEW ROBERT</creator><creator>TIDWELL, MICHAEL WADE</creator><creator>BOYD, STEVEN ARMEN</creator><creator>LEE, WAI-MAN</creator><creator>CONWAY, RICHARD GERARD</creator><creator>HELLMAN, SARAH LYNNE</creator><creator>GALKA, CHRISTOPHER STANLEY</creator><creator>ROTHHAAR, ROGER RYAN</creator><creator>WILLIAMS, ANDREW CAERWYN</creator><creator>DEO, ARUNDHATI S</creator><creator>ZHANG, DEYI</creator><creator>VICTOR, FRANTZ</creator><creator>MARTINEZ-GRAU, MARIA ANGELES</creator><scope>EVB</scope></search><sort><creationdate>20120426</creationdate><title>6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists</title><author>SIEDEM, CHRISTOPHER STEPHEN ; BRINER, KARIN ; RODRIGUEZ, MICHAEL JOHN ; SINGH, AJAY ; MAZANETZ, MICHAEL PHILIP ; ALLEN, JOHN GORDON ; COHEN, MICHAEL PHILIP ; REINHARD, MATTHEW ROBERT ; TIDWELL, MICHAEL WADE ; BOYD, STEVEN ARMEN ; LEE, WAI-MAN ; CONWAY, RICHARD GERARD ; HELLMAN, SARAH LYNNE ; GALKA, CHRISTOPHER STANLEY ; ROTHHAAR, ROGER RYAN ; WILLIAMS, ANDREW CAERWYN ; DEO, ARUNDHATI S ; ZHANG, DEYI ; VICTOR, FRANTZ ; MARTINEZ-GRAU, MARIA ANGELES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2011202788BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>SIEDEM, CHRISTOPHER STEPHEN</creatorcontrib><creatorcontrib>BRINER, KARIN</creatorcontrib><creatorcontrib>RODRIGUEZ, MICHAEL JOHN</creatorcontrib><creatorcontrib>SINGH, AJAY</creatorcontrib><creatorcontrib>MAZANETZ, MICHAEL PHILIP</creatorcontrib><creatorcontrib>ALLEN, JOHN GORDON</creatorcontrib><creatorcontrib>COHEN, MICHAEL PHILIP</creatorcontrib><creatorcontrib>REINHARD, MATTHEW ROBERT</creatorcontrib><creatorcontrib>TIDWELL, MICHAEL WADE</creatorcontrib><creatorcontrib>BOYD, STEVEN ARMEN</creatorcontrib><creatorcontrib>LEE, WAI-MAN</creatorcontrib><creatorcontrib>CONWAY, RICHARD GERARD</creatorcontrib><creatorcontrib>HELLMAN, SARAH LYNNE</creatorcontrib><creatorcontrib>GALKA, CHRISTOPHER STANLEY</creatorcontrib><creatorcontrib>ROTHHAAR, ROGER RYAN</creatorcontrib><creatorcontrib>WILLIAMS, ANDREW CAERWYN</creatorcontrib><creatorcontrib>DEO, ARUNDHATI S</creatorcontrib><creatorcontrib>ZHANG, DEYI</creatorcontrib><creatorcontrib>VICTOR, FRANTZ</creatorcontrib><creatorcontrib>MARTINEZ-GRAU, MARIA ANGELES</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SIEDEM, CHRISTOPHER STEPHEN</au><au>BRINER, KARIN</au><au>RODRIGUEZ, MICHAEL JOHN</au><au>SINGH, AJAY</au><au>MAZANETZ, MICHAEL PHILIP</au><au>ALLEN, JOHN GORDON</au><au>COHEN, MICHAEL PHILIP</au><au>REINHARD, MATTHEW ROBERT</au><au>TIDWELL, MICHAEL WADE</au><au>BOYD, STEVEN ARMEN</au><au>LEE, WAI-MAN</au><au>CONWAY, RICHARD GERARD</au><au>HELLMAN, SARAH LYNNE</au><au>GALKA, CHRISTOPHER STANLEY</au><au>ROTHHAAR, ROGER RYAN</au><au>WILLIAMS, ANDREW CAERWYN</au><au>DEO, ARUNDHATI S</au><au>ZHANG, DEYI</au><au>VICTOR, FRANTZ</au><au>MARTINEZ-GRAU, MARIA ANGELES</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists</title><date>2012-04-26</date><risdate>2012</risdate><abstract>6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1 H BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS Abstract Rr R R 4 R N-R 3 (I) The present invention provides 6-substituted 2,3,4,5-tetrahydro- 1 H benzo[d]azepines of Formula I as selective 5-HT2C receptor agonists for the treatment of 5-HT2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: I where R is -C= C-R'0 , -O-R , -S-R' 4 , or NR 24R ; and other substituents are as defined in the specification. (5273342_l):KZA</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2011202788BB2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T12%3A44%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SIEDEM,%20CHRISTOPHER%20STEPHEN&rft.date=2012-04-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2011202788BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true